Risuteganib
Risuteganib Uses, Dosage, Side Effects, Food Interaction and all others data.
Risuteganib is under investigation in clinical trial NCT02348918 (Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema).
| Trade Name | Risuteganib |
| Generic | Risuteganib |
| Risuteganib Other Names | Risuteganib |
| Type | |
| Formula | C22H39N9O11S |
| Weight | Average: 637.67 Monoisotopic: 637.248974286 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Risuteganib
